NOVITIUM PHARMA FDA Approval ANDA 212252

ANDA 212252

NOVITIUM PHARMA

FDA Drug Application

Application #212252

Application Sponsors

ANDA 212252NOVITIUM PHARMA

Marketing Status

Prescription001

Application Products

001SUSPENSION;ORAL200MG/5ML0ACYCLOVIRACYCLOVIR

FDA Submissions

UNKNOWN; ORIG1AP2020-07-10STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

NOVITIUM PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212252
            [companyName] => NOVITIUM PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"ACYCLOVIR","activeIngredients":"ACYCLOVIR","strength":"200MG\/5ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/10\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-07-10
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.